Funded by the NIH HEAL Initiative®
This project will develop models to predict individual patient’s risk for relapse (or dropout from treatment) when treated with medications for OUD including methadone, buprenorphine, or extended-release depot naltrexone.
Sean Luo, MD, Ph.D.
Assistant Professor
Columbia University
1051 Riverside Drive, Unit 66, New York, NY, 10033, US
Daniel J. Feaster, Ph.D.
Associate Professor, Senior Biostatician
University of Miami Miller School of Medicine
1120 NW 14th Street, Suite 1059, Miami, FL, 33136, US
CTN-0094 completed